This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Financial implications During the transition to a dollarized economy, global companies may face challenges in hedging due to foreign exchange fluctuations, necessitating careful currency riskmanagement and financial strategy adaptation to maintain profitability.
John Bree will also be moderating a RiskManagement Panel on Third-party COVID-19 Disruption. . Risk leaders discuss current capabilities and future solutions to help companies better understand the risks involved and enable better ongoing assessment and continuous monitoring of their third parties. .
Economic interdependence and globalization have bolstered the global economy, growing the global gross domestic product (GDP) by USD 25 trillion between 2000 and 2016. Successful companies know how to source resources in the most cost-effective way, including those that aren’t readily available in their primary locations.
So as trials become more complex, you have more data sources, you’re working with more vendors. So these use cases could be RBQM, riskmanagement. Certainly you’ll monitor these as you go along, but they’re much more accurate then how that risk identification and management process is, ongoing.
We organize all of the trending information in your field so you don't have to. Join 19,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content